Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.28 | -17.78 |
| PEG Ratio (TTM) | 0.01 | -5.55 |
| P/S Ratio (TTM) | N/A | 39.43 |
| P/B Ratio (TTM) | -31.09 | 5.80 |
| P/FCF Ratio (TTM) | -9,396.98 | -146.47 |
| Price to 5YR AVG Earnings Ratio | 0.03 | -34.01 |
| Price to 5YR AVG FCF Ratio | -0.73 | -1.00 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 288.99% |
| ROE (TTM) | 950.12% | -4,244.29% |
| Net Profit Margin (TTM) | N/A | -1,050.76% |
| ROIC 5YR AVG | 6.59% | -15.85% |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 49.34% | 88.06% | 72.08% |
| Revenue | N/A | 98.70% | 39.22% |
| Net Income | -2.19% | 412.27% | 87,452.82% |
| Cash Flow | 375.85% | 2,266.96% | 30,633.21% |
Health (11%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.49 | 4.94 |
| Quick Ratio (TTM) | 0.49 | 4.92 |
| D/E Ratio (TTM) | N/A | 1.30 |
| Interest Coverage (TTM) | N/A | -11.46 |
| Piotroski F-Score | 3 | 3 |
| Altman Z-Score | N/A | 21.03 |
| LTL to 5YR AVG FCF | N/A | -0.53 |
| Shares Outstanding Growth 5YR AVG | 39,183.23% | 892.04% |